nodes	percent_of_prediction	percent_of_DWPC	metapath
Homatropine Methylbromide—Ipratropium bromide—SLC22A4—Crohn's disease	0.111	0.571	CrCbGaD
Homatropine Methylbromide—Ipratropium bromide—SLC22A5—Crohn's disease	0.0832	0.429	CrCbGaD
Homatropine Methylbromide—CHRM4—Signaling by GPCR—CCR9—Crohn's disease	0.00237	0.00294	CbGpPWpGaD
Homatropine Methylbromide—CHRM2—Class A/1 (Rhodopsin-like receptors)—PTGER4—Crohn's disease	0.00235	0.00292	CbGpPWpGaD
Homatropine Methylbromide—CHRM5—GPCR downstream signaling—GPR65—Crohn's disease	0.00232	0.00288	CbGpPWpGaD
Homatropine Methylbromide—CHRM1—Signaling by GPCR—MLN—Crohn's disease	0.0023	0.00286	CbGpPWpGaD
Homatropine Methylbromide—CHRM3—Signaling by GPCR—MLN—Crohn's disease	0.0023	0.00285	CbGpPWpGaD
Homatropine Methylbromide—CHRM2—Signaling by GPCR—MLN—Crohn's disease	0.00227	0.00282	CbGpPWpGaD
Homatropine Methylbromide—CHRM5—Signaling by GPCR—CCR9—Crohn's disease	0.00227	0.00281	CbGpPWpGaD
Homatropine Methylbromide—CHRM4—Signaling by GPCR—GPR65—Crohn's disease	0.0022	0.00273	CbGpPWpGaD
Homatropine Methylbromide—CHRM4—Signaling Pathways—ACKR2—Crohn's disease	0.00213	0.00264	CbGpPWpGaD
Homatropine Methylbromide—CHRM5—Signaling by GPCR—GPR65—Crohn's disease	0.00211	0.00262	CbGpPWpGaD
Homatropine Methylbromide—CHRM1—GPCR ligand binding—CCR6—Crohn's disease	0.00206	0.00256	CbGpPWpGaD
Homatropine Methylbromide—CHRM3—GPCR ligand binding—CCR6—Crohn's disease	0.00206	0.00255	CbGpPWpGaD
Homatropine Methylbromide—CHRM5—Signaling Pathways—ACKR2—Crohn's disease	0.00204	0.00253	CbGpPWpGaD
Homatropine Methylbromide—CHRM2—GPCR ligand binding—CCR6—Crohn's disease	0.00204	0.00252	CbGpPWpGaD
Homatropine Methylbromide—CHRM4—Signaling Pathways—MLN—Crohn's disease	0.00202	0.0025	CbGpPWpGaD
Homatropine Methylbromide—CHRM5—Signaling Pathways—MLN—Crohn's disease	0.00193	0.0024	CbGpPWpGaD
Homatropine Methylbromide—CHRM5—Gastrin-CREB signalling pathway via PKC and MAPK—TYK2—Crohn's disease	0.00192	0.00238	CbGpPWpGaD
Homatropine Methylbromide—CHRM4—Signaling Pathways—TAGAP—Crohn's disease	0.00185	0.00229	CbGpPWpGaD
Homatropine Methylbromide—CHRM5—Gastrin-CREB signalling pathway via PKC and MAPK—JAK2—Crohn's disease	0.00183	0.00227	CbGpPWpGaD
Homatropine Methylbromide—CHRM1—GPCR ligand binding—PTGER4—Crohn's disease	0.00182	0.00225	CbGpPWpGaD
Homatropine Methylbromide—CHRM3—GPCR ligand binding—PTGER4—Crohn's disease	0.00181	0.00224	CbGpPWpGaD
Homatropine Methylbromide—CHRM2—GPCR ligand binding—PTGER4—Crohn's disease	0.00179	0.00222	CbGpPWpGaD
Homatropine Methylbromide—CHRM5—Signaling Pathways—TAGAP—Crohn's disease	0.00177	0.00219	CbGpPWpGaD
Homatropine Methylbromide—CHRM1—GPCR downstream signaling—CCR9—Crohn's disease	0.00176	0.00218	CbGpPWpGaD
Homatropine Methylbromide—CHRM3—GPCR downstream signaling—CCR9—Crohn's disease	0.00175	0.00218	CbGpPWpGaD
Homatropine Methylbromide—CHRM2—GPCR downstream signaling—CCR9—Crohn's disease	0.00174	0.00215	CbGpPWpGaD
Homatropine Methylbromide—CHRM4—GPCR downstream signaling—CCR6—Crohn's disease	0.00173	0.00214	CbGpPWpGaD
Homatropine Methylbromide—CHRM5—GPCR downstream signaling—CCR6—Crohn's disease	0.00165	0.00205	CbGpPWpGaD
Homatropine Methylbromide—CHRM1—GPCR downstream signaling—GPR65—Crohn's disease	0.00164	0.00203	CbGpPWpGaD
Homatropine Methylbromide—CHRM3—GPCR downstream signaling—GPR65—Crohn's disease	0.00163	0.00202	CbGpPWpGaD
Homatropine Methylbromide—CHRM4—G alpha (i) signalling events—CXCL8—Crohn's disease	0.00163	0.00202	CbGpPWpGaD
Homatropine Methylbromide—CHRM2—GPCR downstream signaling—GPR65—Crohn's disease	0.00161	0.002	CbGpPWpGaD
Homatropine Methylbromide—CHRM4—Signaling Pathways—RSPO3—Crohn's disease	0.00161	0.002	CbGpPWpGaD
Homatropine Methylbromide—CHRM1—Signaling by GPCR—CCR9—Crohn's disease	0.0016	0.00198	CbGpPWpGaD
Homatropine Methylbromide—CHRM3—Signaling by GPCR—CCR9—Crohn's disease	0.00159	0.00198	CbGpPWpGaD
Homatropine Methylbromide—CHRM2—Signaling by GPCR—CCR9—Crohn's disease	0.00158	0.00196	CbGpPWpGaD
Homatropine Methylbromide—CHRM4—Signaling by GPCR—CCR6—Crohn's disease	0.00157	0.00195	CbGpPWpGaD
Homatropine Methylbromide—CHRM5—Signaling Pathways—RSPO3—Crohn's disease	0.00155	0.00192	CbGpPWpGaD
Homatropine Methylbromide—CHRM4—Signaling Pathways—SEL1L—Crohn's disease	0.00153	0.0019	CbGpPWpGaD
Homatropine Methylbromide—CHRM4—GPCR downstream signaling—PTGER4—Crohn's disease	0.00152	0.00189	CbGpPWpGaD
Homatropine Methylbromide—CHRM2—SIDS Susceptibility Pathways—CXCL8—Crohn's disease	0.0015	0.00187	CbGpPWpGaD
Homatropine Methylbromide—CHRM5—Signaling by GPCR—CCR6—Crohn's disease	0.0015	0.00186	CbGpPWpGaD
Homatropine Methylbromide—CHRM1—Signaling by GPCR—GPR65—Crohn's disease	0.00148	0.00184	CbGpPWpGaD
Homatropine Methylbromide—CHRM3—Metabolism—PLA2G4F—Crohn's disease	0.00148	0.00184	CbGpPWpGaD
Homatropine Methylbromide—CHRM3—Signaling by GPCR—GPR65—Crohn's disease	0.00148	0.00184	CbGpPWpGaD
Homatropine Methylbromide—CHRM2—Signaling by GPCR—GPR65—Crohn's disease	0.00147	0.00182	CbGpPWpGaD
Homatropine Methylbromide—CHRM5—Signaling Pathways—SEL1L—Crohn's disease	0.00147	0.00182	CbGpPWpGaD
Homatropine Methylbromide—CHRM5—GPCR downstream signaling—PTGER4—Crohn's disease	0.00146	0.00181	CbGpPWpGaD
Homatropine Methylbromide—CHRM2—SIDS Susceptibility Pathways—IL1B—Crohn's disease	0.00144	0.00179	CbGpPWpGaD
Homatropine Methylbromide—CHRM1—Signaling Pathways—ACKR2—Crohn's disease	0.00144	0.00178	CbGpPWpGaD
Homatropine Methylbromide—CHRM3—Signaling Pathways—ACKR2—Crohn's disease	0.00143	0.00178	CbGpPWpGaD
Homatropine Methylbromide—CHRM2—Signaling Pathways—ACKR2—Crohn's disease	0.00142	0.00176	CbGpPWpGaD
Homatropine Methylbromide—CHRM4—Signaling Pathways—CCR9—Crohn's disease	0.0014	0.00174	CbGpPWpGaD
Homatropine Methylbromide—CHRM4—Signaling by GPCR—PTGER4—Crohn's disease	0.00138	0.00171	CbGpPWpGaD
Homatropine Methylbromide—CHRM1—Signaling Pathways—MLN—Crohn's disease	0.00136	0.00169	CbGpPWpGaD
Homatropine Methylbromide—CHRM3—Signaling Pathways—MLN—Crohn's disease	0.00136	0.00168	CbGpPWpGaD
Homatropine Methylbromide—CHRM1—Gastrin-CREB signalling pathway via PKC and MAPK—TYK2—Crohn's disease	0.00135	0.00168	CbGpPWpGaD
Homatropine Methylbromide—CHRM3—Gastrin-CREB signalling pathway via PKC and MAPK—TYK2—Crohn's disease	0.00135	0.00167	CbGpPWpGaD
Homatropine Methylbromide—CHRM2—Signaling Pathways—MLN—Crohn's disease	0.00134	0.00167	CbGpPWpGaD
Homatropine Methylbromide—CHRM5—Signaling Pathways—CCR9—Crohn's disease	0.00134	0.00166	CbGpPWpGaD
Homatropine Methylbromide—CHRM5—Signaling by GPCR—PTGER4—Crohn's disease	0.00132	0.00164	CbGpPWpGaD
Homatropine Methylbromide—CHRM4—Signaling Pathways—GPR65—Crohn's disease	0.0013	0.00161	CbGpPWpGaD
Homatropine Methylbromide—CHRM4—GPCR downstream signaling—IL3—Crohn's disease	0.0013	0.00161	CbGpPWpGaD
Homatropine Methylbromide—CHRM4—Class A/1 (Rhodopsin-like receptors)—CXCL8—Crohn's disease	0.00129	0.00161	CbGpPWpGaD
Homatropine Methylbromide—CHRM1—Gastrin-CREB signalling pathway via PKC and MAPK—JAK2—Crohn's disease	0.00129	0.0016	CbGpPWpGaD
Homatropine Methylbromide—CHRM3—Gastrin-CREB signalling pathway via PKC and MAPK—JAK2—Crohn's disease	0.00129	0.0016	CbGpPWpGaD
Homatropine Methylbromide—CHRM3—Metabolism—MTMR3—Crohn's disease	0.00126	0.00157	CbGpPWpGaD
Homatropine Methylbromide—CHRM4—GPCR downstream signaling—RASGRP1—Crohn's disease	0.00125	0.00155	CbGpPWpGaD
Homatropine Methylbromide—CHRM5—Signaling Pathways—GPR65—Crohn's disease	0.00125	0.00155	CbGpPWpGaD
Homatropine Methylbromide—CHRM1—Signaling Pathways—TAGAP—Crohn's disease	0.00125	0.00154	CbGpPWpGaD
Homatropine Methylbromide—CHRM3—Signaling Pathways—TAGAP—Crohn's disease	0.00124	0.00154	CbGpPWpGaD
Homatropine Methylbromide—CHRM5—GPCR downstream signaling—IL3—Crohn's disease	0.00124	0.00154	CbGpPWpGaD
Homatropine Methylbromide—CHRM5—Class A/1 (Rhodopsin-like receptors)—CXCL8—Crohn's disease	0.00124	0.00154	CbGpPWpGaD
Homatropine Methylbromide—CHRM2—Signaling Pathways—TAGAP—Crohn's disease	0.00123	0.00152	CbGpPWpGaD
Homatropine Methylbromide—CHRM5—GPCR downstream signaling—RASGRP1—Crohn's disease	0.0012	0.00149	CbGpPWpGaD
Homatropine Methylbromide—CHRM4—Signaling by GPCR—IL3—Crohn's disease	0.00118	0.00146	CbGpPWpGaD
Homatropine Methylbromide—CHRM1—GPCR downstream signaling—CCR6—Crohn's disease	0.00117	0.00145	CbGpPWpGaD
Homatropine Methylbromide—CHRM3—GPCR downstream signaling—CCR6—Crohn's disease	0.00116	0.00144	CbGpPWpGaD
Homatropine Methylbromide—CHRM2—GPCR downstream signaling—CCR6—Crohn's disease	0.00115	0.00143	CbGpPWpGaD
Homatropine Methylbromide—CHRM4—Signaling by GPCR—RASGRP1—Crohn's disease	0.00114	0.00141	CbGpPWpGaD
Homatropine Methylbromide—CHRM5—Signaling by GPCR—IL3—Crohn's disease	0.00113	0.0014	CbGpPWpGaD
Homatropine Methylbromide—CHRM5—Signaling by GPCR—RASGRP1—Crohn's disease	0.00109	0.00135	CbGpPWpGaD
Homatropine Methylbromide—CHRM1—Signaling Pathways—RSPO3—Crohn's disease	0.00109	0.00135	CbGpPWpGaD
Homatropine Methylbromide—CHRM3—Signaling Pathways—RSPO3—Crohn's disease	0.00108	0.00135	CbGpPWpGaD
Homatropine Methylbromide—CHRM2—G alpha (i) signalling events—CXCL8—Crohn's disease	0.00108	0.00134	CbGpPWpGaD
Homatropine Methylbromide—CHRM2—Signaling Pathways—RSPO3—Crohn's disease	0.00107	0.00133	CbGpPWpGaD
Homatropine Methylbromide—CHRM1—Signaling by GPCR—CCR6—Crohn's disease	0.00106	0.00131	CbGpPWpGaD
Homatropine Methylbromide—CHRM3—Signaling by GPCR—CCR6—Crohn's disease	0.00105	0.00131	CbGpPWpGaD
Homatropine Methylbromide—CHRM2—SIDS Susceptibility Pathways—TNF—Crohn's disease	0.00105	0.0013	CbGpPWpGaD
Homatropine Methylbromide—CHRM2—Signaling by GPCR—CCR6—Crohn's disease	0.00104	0.0013	CbGpPWpGaD
Homatropine Methylbromide—CHRM1—Signaling Pathways—SEL1L—Crohn's disease	0.00103	0.00128	CbGpPWpGaD
Homatropine Methylbromide—CHRM3—Signaling Pathways—SEL1L—Crohn's disease	0.00103	0.00128	CbGpPWpGaD
Homatropine Methylbromide—CHRM1—GPCR downstream signaling—PTGER4—Crohn's disease	0.00103	0.00127	CbGpPWpGaD
Homatropine Methylbromide—CHRM3—GPCR downstream signaling—PTGER4—Crohn's disease	0.00102	0.00127	CbGpPWpGaD
Homatropine Methylbromide—CHRM2—Signaling Pathways—SEL1L—Crohn's disease	0.00102	0.00126	CbGpPWpGaD
Homatropine Methylbromide—CHRM2—GPCR downstream signaling—PTGER4—Crohn's disease	0.00101	0.00126	CbGpPWpGaD
Homatropine Methylbromide—CHRM4—GPCR ligand binding—CXCL8—Crohn's disease	0.000985	0.00122	CbGpPWpGaD
Homatropine Methylbromide—CHRM3—Metabolism—FADS1—Crohn's disease	0.000983	0.00122	CbGpPWpGaD
Homatropine Methylbromide—CHRM5—GPCR ligand binding—CXCL8—Crohn's disease	0.000944	0.00117	CbGpPWpGaD
Homatropine Methylbromide—CHRM1—Signaling Pathways—CCR9—Crohn's disease	0.000944	0.00117	CbGpPWpGaD
Homatropine Methylbromide—CHRM3—Signaling Pathways—CCR9—Crohn's disease	0.000941	0.00117	CbGpPWpGaD
Homatropine Methylbromide—CHRM5—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—Crohn's disease	0.00094	0.00117	CbGpPWpGaD
Homatropine Methylbromide—CHRM1—Signaling by GPCR—PTGER4—Crohn's disease	0.000932	0.00116	CbGpPWpGaD
Homatropine Methylbromide—CHRM2—Signaling Pathways—CCR9—Crohn's disease	0.000931	0.00116	CbGpPWpGaD
Homatropine Methylbromide—CHRM3—Signaling by GPCR—PTGER4—Crohn's disease	0.000929	0.00115	CbGpPWpGaD
Homatropine Methylbromide—CHRM4—Signaling Pathways—CCR6—Crohn's disease	0.000927	0.00115	CbGpPWpGaD
Homatropine Methylbromide—CHRM3—Metabolism—GPX4—Crohn's disease	0.000921	0.00114	CbGpPWpGaD
Homatropine Methylbromide—CHRM2—Signaling by GPCR—PTGER4—Crohn's disease	0.00092	0.00114	CbGpPWpGaD
Homatropine Methylbromide—CHRM4—GPCR downstream signaling—IL2RA—Crohn's disease	0.000908	0.00113	CbGpPWpGaD
Homatropine Methylbromide—CHRM3—Metabolism—GCKR—Crohn's disease	0.000889	0.0011	CbGpPWpGaD
Homatropine Methylbromide—CHRM5—Signaling Pathways—CCR6—Crohn's disease	0.000888	0.0011	CbGpPWpGaD
Homatropine Methylbromide—CHRM1—Signaling Pathways—GPR65—Crohn's disease	0.000877	0.00109	CbGpPWpGaD
Homatropine Methylbromide—CHRM3—Signaling Pathways—GPR65—Crohn's disease	0.000874	0.00108	CbGpPWpGaD
Homatropine Methylbromide—CHRM1—GPCR downstream signaling—IL3—Crohn's disease	0.000874	0.00108	CbGpPWpGaD
Homatropine Methylbromide—CHRM1—Class A/1 (Rhodopsin-like receptors)—CXCL8—Crohn's disease	0.000872	0.00108	CbGpPWpGaD
Homatropine Methylbromide—CHRM3—GPCR downstream signaling—IL3—Crohn's disease	0.000871	0.00108	CbGpPWpGaD
Homatropine Methylbromide—CHRM3—Class A/1 (Rhodopsin-like receptors)—CXCL8—Crohn's disease	0.00087	0.00108	CbGpPWpGaD
Homatropine Methylbromide—CHRM5—GPCR downstream signaling—IL2RA—Crohn's disease	0.000869	0.00108	CbGpPWpGaD
Homatropine Methylbromide—CHRM2—Signaling Pathways—GPR65—Crohn's disease	0.000866	0.00107	CbGpPWpGaD
Homatropine Methylbromide—CHRM2—GPCR downstream signaling—IL3—Crohn's disease	0.000862	0.00107	CbGpPWpGaD
Homatropine Methylbromide—CHRM2—Class A/1 (Rhodopsin-like receptors)—CXCL8—Crohn's disease	0.000861	0.00107	CbGpPWpGaD
Homatropine Methylbromide—CHRM1—GPCR downstream signaling—RASGRP1—Crohn's disease	0.000845	0.00105	CbGpPWpGaD
Homatropine Methylbromide—CHRM2—SIDS Susceptibility Pathways—IL6—Crohn's disease	0.000844	0.00105	CbGpPWpGaD
Homatropine Methylbromide—CHRM3—GPCR downstream signaling—RASGRP1—Crohn's disease	0.000842	0.00105	CbGpPWpGaD
Homatropine Methylbromide—CHRM4—Signaling Pathways—RBX1—Crohn's disease	0.000838	0.00104	CbGpPWpGaD
Homatropine Methylbromide—CHRM2—GPCR downstream signaling—RASGRP1—Crohn's disease	0.000834	0.00103	CbGpPWpGaD
Homatropine Methylbromide—CHRM4—Signaling by GPCR—IL2RA—Crohn's disease	0.000824	0.00102	CbGpPWpGaD
Homatropine Methylbromide—CHRM4—Signaling Pathways—PTGER4—Crohn's disease	0.000816	0.00101	CbGpPWpGaD
Homatropine Methylbromide—CHRM5—Signaling Pathways—RBX1—Crohn's disease	0.000803	0.000996	CbGpPWpGaD
Homatropine Methylbromide—CHRM1—Signaling by GPCR—IL3—Crohn's disease	0.000793	0.000984	CbGpPWpGaD
Homatropine Methylbromide—CHRM3—Signaling by GPCR—IL3—Crohn's disease	0.000791	0.000981	CbGpPWpGaD
Homatropine Methylbromide—CHRM5—Signaling by GPCR—IL2RA—Crohn's disease	0.000789	0.000979	CbGpPWpGaD
Homatropine Methylbromide—CHRM2—Signaling by GPCR—IL3—Crohn's disease	0.000783	0.000972	CbGpPWpGaD
Homatropine Methylbromide—CHRM5—Signaling Pathways—PTGER4—Crohn's disease	0.000782	0.00097	CbGpPWpGaD
Homatropine Methylbromide—CHRM1—Signaling by GPCR—RASGRP1—Crohn's disease	0.000767	0.000952	CbGpPWpGaD
Homatropine Methylbromide—CHRM3—Signaling by GPCR—RASGRP1—Crohn's disease	0.000765	0.000949	CbGpPWpGaD
Homatropine Methylbromide—CHRM2—Signaling by GPCR—RASGRP1—Crohn's disease	0.000758	0.00094	CbGpPWpGaD
Homatropine Methylbromide—CHRM4—Signaling Pathways—UBE2D1—Crohn's disease	0.000735	0.000912	CbGpPWpGaD
Homatropine Methylbromide—CHRM4—Signaling Pathways—RIPK2—Crohn's disease	0.000713	0.000884	CbGpPWpGaD
Homatropine Methylbromide—CHRM5—Signaling Pathways—UBE2D1—Crohn's disease	0.000704	0.000873	CbGpPWpGaD
Homatropine Methylbromide—CHRM1—Circadian rythm related genes—IL6—Crohn's disease	0.000698	0.000867	CbGpPWpGaD
Homatropine Methylbromide—CHRM4—Signaling Pathways—IL3—Crohn's disease	0.000695	0.000862	CbGpPWpGaD
Homatropine Methylbromide—CHRM5—Signaling Pathways—RIPK2—Crohn's disease	0.000683	0.000847	CbGpPWpGaD
Homatropine Methylbromide—CHRM4—Signaling Pathways—RASGRP1—Crohn's disease	0.000672	0.000834	CbGpPWpGaD
Homatropine Methylbromide—CHRM5—Signaling Pathways—IL3—Crohn's disease	0.000666	0.000826	CbGpPWpGaD
Homatropine Methylbromide—CHRM1—GPCR ligand binding—CXCL8—Crohn's disease	0.000664	0.000824	CbGpPWpGaD
Homatropine Methylbromide—CHRM3—GPCR ligand binding—CXCL8—Crohn's disease	0.000662	0.000822	CbGpPWpGaD
Homatropine Methylbromide—CHRM1—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—Crohn's disease	0.000662	0.000821	CbGpPWpGaD
Homatropine Methylbromide—CHRM3—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—Crohn's disease	0.00066	0.000818	CbGpPWpGaD
Homatropine Methylbromide—CHRM2—GPCR ligand binding—CXCL8—Crohn's disease	0.000656	0.000814	CbGpPWpGaD
Homatropine Methylbromide—CHRM5—Signaling Pathways—RASGRP1—Crohn's disease	0.000644	0.000799	CbGpPWpGaD
Homatropine Methylbromide—CHRM1—Signaling Pathways—CCR6—Crohn's disease	0.000625	0.000775	CbGpPWpGaD
Homatropine Methylbromide—CHRM3—Signaling Pathways—CCR6—Crohn's disease	0.000623	0.000773	CbGpPWpGaD
Homatropine Methylbromide—CHRM2—Signaling Pathways—CCR6—Crohn's disease	0.000617	0.000765	CbGpPWpGaD
Homatropine Methylbromide—CHRM1—GPCR downstream signaling—IL2RA—Crohn's disease	0.000612	0.000759	CbGpPWpGaD
Homatropine Methylbromide—CHRM4—GPCR downstream signaling—JAK2—Crohn's disease	0.00061	0.000757	CbGpPWpGaD
Homatropine Methylbromide—CHRM3—GPCR downstream signaling—IL2RA—Crohn's disease	0.00061	0.000757	CbGpPWpGaD
Homatropine Methylbromide—CHRM4—Signaling Pathways—SOCS1—Crohn's disease	0.000609	0.000756	CbGpPWpGaD
Homatropine Methylbromide—CHRM2—GPCR downstream signaling—IL2RA—Crohn's disease	0.000604	0.00075	CbGpPWpGaD
Homatropine Methylbromide—CHRM5—GPCR downstream signaling—JAK2—Crohn's disease	0.000584	0.000725	CbGpPWpGaD
Homatropine Methylbromide—CHRM5—Signaling Pathways—SOCS1—Crohn's disease	0.000583	0.000724	CbGpPWpGaD
Homatropine Methylbromide—CHRM4—Signaling by GPCR—TYK2—Crohn's disease	0.000581	0.00072	CbGpPWpGaD
Homatropine Methylbromide—CHRM1—Signaling Pathways—RBX1—Crohn's disease	0.000565	0.000701	CbGpPWpGaD
Homatropine Methylbromide—CHRM3—Signaling Pathways—RBX1—Crohn's disease	0.000563	0.000699	CbGpPWpGaD
Homatropine Methylbromide—CHRM2—Signaling Pathways—RBX1—Crohn's disease	0.000558	0.000692	CbGpPWpGaD
Homatropine Methylbromide—CHRM4—GPCR downstream signaling—CXCL8—Crohn's disease	0.000557	0.000691	CbGpPWpGaD
Homatropine Methylbromide—CHRM5—Signaling by GPCR—TYK2—Crohn's disease	0.000556	0.00069	CbGpPWpGaD
Homatropine Methylbromide—CHRM1—Signaling by GPCR—IL2RA—Crohn's disease	0.000556	0.00069	CbGpPWpGaD
Homatropine Methylbromide—CHRM3—Signaling by GPCR—IL2RA—Crohn's disease	0.000554	0.000687	CbGpPWpGaD
Homatropine Methylbromide—CHRM4—Signaling by GPCR—JAK2—Crohn's disease	0.000554	0.000687	CbGpPWpGaD
Homatropine Methylbromide—CHRM1—Signaling Pathways—PTGER4—Crohn's disease	0.00055	0.000683	CbGpPWpGaD
Homatropine Methylbromide—CHRM2—Signaling by GPCR—IL2RA—Crohn's disease	0.000549	0.000681	CbGpPWpGaD
Homatropine Methylbromide—CHRM3—Signaling Pathways—PTGER4—Crohn's disease	0.000549	0.00068	CbGpPWpGaD
Homatropine Methylbromide—CHRM2—Signaling Pathways—PTGER4—Crohn's disease	0.000543	0.000674	CbGpPWpGaD
Homatropine Methylbromide—CHRM5—GPCR downstream signaling—CXCL8—Crohn's disease	0.000533	0.000662	CbGpPWpGaD
Homatropine Methylbromide—CHRM5—Signaling by GPCR—JAK2—Crohn's disease	0.000531	0.000658	CbGpPWpGaD
Homatropine Methylbromide—CHRM4—Signaling Pathways—SMAD3—Crohn's disease	0.000526	0.000652	CbGpPWpGaD
Homatropine Methylbromide—CHRM4—Signaling by GPCR—CXCL8—Crohn's disease	0.000506	0.000627	CbGpPWpGaD
Homatropine Methylbromide—CHRM5—Signaling Pathways—SMAD3—Crohn's disease	0.000504	0.000625	CbGpPWpGaD
Homatropine Methylbromide—CHRM1—Signaling Pathways—UBE2D1—Crohn's disease	0.000496	0.000615	CbGpPWpGaD
Homatropine Methylbromide—CHRM3—Signaling Pathways—UBE2D1—Crohn's disease	0.000494	0.000613	CbGpPWpGaD
Homatropine Methylbromide—CHRM2—Signaling Pathways—UBE2D1—Crohn's disease	0.000489	0.000607	CbGpPWpGaD
Homatropine Methylbromide—CHRM4—Signaling Pathways—IL2RA—Crohn's disease	0.000487	0.000604	CbGpPWpGaD
Homatropine Methylbromide—CHRM5—Signaling by GPCR—CXCL8—Crohn's disease	0.000484	0.000601	CbGpPWpGaD
Homatropine Methylbromide—CHRM1—Signaling Pathways—RIPK2—Crohn's disease	0.000481	0.000596	CbGpPWpGaD
Homatropine Methylbromide—CHRM3—Signaling Pathways—RIPK2—Crohn's disease	0.000479	0.000594	CbGpPWpGaD
Homatropine Methylbromide—CHRM2—Signaling Pathways—RIPK2—Crohn's disease	0.000474	0.000589	CbGpPWpGaD
Homatropine Methylbromide—CHRM1—Signaling Pathways—IL3—Crohn's disease	0.000469	0.000581	CbGpPWpGaD
Homatropine Methylbromide—CHRM3—Signaling Pathways—IL3—Crohn's disease	0.000467	0.00058	CbGpPWpGaD
Homatropine Methylbromide—CHRM5—Signaling Pathways—IL2RA—Crohn's disease	0.000466	0.000578	CbGpPWpGaD
Homatropine Methylbromide—CHRM2—Signaling Pathways—IL3—Crohn's disease	0.000463	0.000574	CbGpPWpGaD
Homatropine Methylbromide—CHRM1—Signaling Pathways—RASGRP1—Crohn's disease	0.000453	0.000562	CbGpPWpGaD
Homatropine Methylbromide—CHRM3—Signaling Pathways—RASGRP1—Crohn's disease	0.000452	0.000561	CbGpPWpGaD
Homatropine Methylbromide—CHRM2—Signaling Pathways—RASGRP1—Crohn's disease	0.000447	0.000555	CbGpPWpGaD
Homatropine Methylbromide—CHRM1—GPCR downstream signaling—JAK2—Crohn's disease	0.000411	0.00051	CbGpPWpGaD
Homatropine Methylbromide—CHRM1—Signaling Pathways—SOCS1—Crohn's disease	0.000411	0.00051	CbGpPWpGaD
Homatropine Methylbromide—CHRM3—GPCR downstream signaling—JAK2—Crohn's disease	0.00041	0.000509	CbGpPWpGaD
Homatropine Methylbromide—CHRM3—Signaling Pathways—SOCS1—Crohn's disease	0.000409	0.000508	CbGpPWpGaD
Homatropine Methylbromide—CHRM2—GPCR downstream signaling—JAK2—Crohn's disease	0.000406	0.000504	CbGpPWpGaD
Homatropine Methylbromide—CHRM2—Signaling Pathways—SOCS1—Crohn's disease	0.000405	0.000503	CbGpPWpGaD
Homatropine Methylbromide—CHRM1—Signaling by GPCR—TYK2—Crohn's disease	0.000392	0.000486	CbGpPWpGaD
Homatropine Methylbromide—CHRM3—Signaling by GPCR—TYK2—Crohn's disease	0.00039	0.000484	CbGpPWpGaD
Homatropine Methylbromide—CHRM2—Signaling by GPCR—TYK2—Crohn's disease	0.000387	0.00048	CbGpPWpGaD
Homatropine Methylbromide—CHRM1—GPCR downstream signaling—CXCL8—Crohn's disease	0.000375	0.000466	CbGpPWpGaD
Homatropine Methylbromide—CHRM3—GPCR downstream signaling—CXCL8—Crohn's disease	0.000374	0.000464	CbGpPWpGaD
Homatropine Methylbromide—CHRM1—Signaling by GPCR—JAK2—Crohn's disease	0.000374	0.000463	CbGpPWpGaD
Homatropine Methylbromide—CHRM3—Signaling by GPCR—JAK2—Crohn's disease	0.000372	0.000462	CbGpPWpGaD
Homatropine Methylbromide—CHRM2—GPCR downstream signaling—CXCL8—Crohn's disease	0.000371	0.00046	CbGpPWpGaD
Homatropine Methylbromide—CHRM2—Signaling by GPCR—JAK2—Crohn's disease	0.000369	0.000457	CbGpPWpGaD
Homatropine Methylbromide—CHRM1—Signaling Pathways—SMAD3—Crohn's disease	0.000355	0.00044	CbGpPWpGaD
Homatropine Methylbromide—CHRM3—Signaling Pathways—SMAD3—Crohn's disease	0.000353	0.000439	CbGpPWpGaD
Homatropine Methylbromide—CHRM2—Signaling Pathways—SMAD3—Crohn's disease	0.00035	0.000434	CbGpPWpGaD
Homatropine Methylbromide—CHRM4—Signaling Pathways—TYK2—Crohn's disease	0.000343	0.000426	CbGpPWpGaD
Homatropine Methylbromide—CHRM1—Signaling by GPCR—CXCL8—Crohn's disease	0.000341	0.000423	CbGpPWpGaD
Homatropine Methylbromide—CHRM3—Signaling by GPCR—CXCL8—Crohn's disease	0.00034	0.000422	CbGpPWpGaD
Homatropine Methylbromide—CHRM2—Signaling by GPCR—CXCL8—Crohn's disease	0.000337	0.000418	CbGpPWpGaD
Homatropine Methylbromide—CHRM5—Signaling Pathways—TYK2—Crohn's disease	0.000329	0.000408	CbGpPWpGaD
Homatropine Methylbromide—CHRM1—Signaling Pathways—IL2RA—Crohn's disease	0.000328	0.000407	CbGpPWpGaD
Homatropine Methylbromide—CHRM4—Signaling Pathways—JAK2—Crohn's disease	0.000327	0.000406	CbGpPWpGaD
Homatropine Methylbromide—CHRM3—Signaling Pathways—IL2RA—Crohn's disease	0.000327	0.000406	CbGpPWpGaD
Homatropine Methylbromide—CHRM2—Signaling Pathways—IL2RA—Crohn's disease	0.000324	0.000402	CbGpPWpGaD
Homatropine Methylbromide—CHRM5—Signaling Pathways—JAK2—Crohn's disease	0.000313	0.000389	CbGpPWpGaD
Homatropine Methylbromide—CHRM4—Signaling Pathways—CXCL8—Crohn's disease	0.000299	0.000371	CbGpPWpGaD
Homatropine Methylbromide—CHRM5—Signaling Pathways—CXCL8—Crohn's disease	0.000286	0.000355	CbGpPWpGaD
Homatropine Methylbromide—CHRM4—Signaling by GPCR—IL6—Crohn's disease	0.000284	0.000352	CbGpPWpGaD
Homatropine Methylbromide—CHRM3—Metabolism—ALB—Crohn's disease	0.000283	0.000351	CbGpPWpGaD
Homatropine Methylbromide—CHRM5—Signaling by GPCR—IL6—Crohn's disease	0.000272	0.000337	CbGpPWpGaD
Homatropine Methylbromide—CHRM3—Metabolism—PTGS2—Crohn's disease	0.000248	0.000307	CbGpPWpGaD
Homatropine Methylbromide—CHRM4—Signaling Pathways—STAT3—Crohn's disease	0.00024	0.000298	CbGpPWpGaD
Homatropine Methylbromide—CHRM1—Signaling Pathways—TYK2—Crohn's disease	0.000231	0.000287	CbGpPWpGaD
Homatropine Methylbromide—CHRM3—Signaling Pathways—TYK2—Crohn's disease	0.000231	0.000286	CbGpPWpGaD
Homatropine Methylbromide—CHRM5—Signaling Pathways—STAT3—Crohn's disease	0.00023	0.000285	CbGpPWpGaD
Homatropine Methylbromide—CHRM2—Signaling Pathways—TYK2—Crohn's disease	0.000228	0.000283	CbGpPWpGaD
Homatropine Methylbromide—CHRM1—Signaling Pathways—JAK2—Crohn's disease	0.000221	0.000274	CbGpPWpGaD
Homatropine Methylbromide—CHRM3—Signaling Pathways—JAK2—Crohn's disease	0.00022	0.000273	CbGpPWpGaD
Homatropine Methylbromide—CHRM2—Signaling Pathways—JAK2—Crohn's disease	0.000218	0.00027	CbGpPWpGaD
Homatropine Methylbromide—CHRM1—Signaling Pathways—CXCL8—Crohn's disease	0.000201	0.00025	CbGpPWpGaD
Homatropine Methylbromide—CHRM3—Signaling Pathways—CXCL8—Crohn's disease	0.000201	0.000249	CbGpPWpGaD
Homatropine Methylbromide—CHRM2—Signaling Pathways—CXCL8—Crohn's disease	0.000199	0.000247	CbGpPWpGaD
Homatropine Methylbromide—CHRM1—Signaling by GPCR—IL6—Crohn's disease	0.000192	0.000238	CbGpPWpGaD
Homatropine Methylbromide—CHRM3—Signaling by GPCR—IL6—Crohn's disease	0.000191	0.000237	CbGpPWpGaD
Homatropine Methylbromide—CHRM2—Signaling by GPCR—IL6—Crohn's disease	0.000189	0.000235	CbGpPWpGaD
Homatropine Methylbromide—CHRM4—Signaling Pathways—IL6—Crohn's disease	0.000168	0.000208	CbGpPWpGaD
Homatropine Methylbromide—CHRM1—Signaling Pathways—STAT3—Crohn's disease	0.000162	0.000201	CbGpPWpGaD
Homatropine Methylbromide—CHRM3—Signaling Pathways—STAT3—Crohn's disease	0.000161	0.0002	CbGpPWpGaD
Homatropine Methylbromide—CHRM5—Signaling Pathways—IL6—Crohn's disease	0.000161	0.000199	CbGpPWpGaD
Homatropine Methylbromide—CHRM2—Signaling Pathways—STAT3—Crohn's disease	0.00016	0.000198	CbGpPWpGaD
Homatropine Methylbromide—CHRM1—Signaling Pathways—IL6—Crohn's disease	0.000113	0.00014	CbGpPWpGaD
Homatropine Methylbromide—CHRM3—Signaling Pathways—IL6—Crohn's disease	0.000113	0.00014	CbGpPWpGaD
Homatropine Methylbromide—CHRM2—Signaling Pathways—IL6—Crohn's disease	0.000112	0.000139	CbGpPWpGaD
